Am J Ophthalmol
December 2020
Am J Ophthalmol
May 2020
Purpose: To compare the effects of 1 year of treatment with trimethoprim-sulfamethoxazole (TMP-SMZ) vs placebo in reducing the risk of recurrence of toxoplasmic retinochoroiditis during a 6-year follow-up period.
Design: Randomized, double-masked clinical trial.
Methods: This cohort included 141 subjects recruited in Campinas, Brazil.